Abstract
The management of oligo-amenorrhea in adolescent patients with polycystic ovary syndrome (PCOS) represents an important and difficult challenge. Metformin and/or oral contraceptives (OCs) are different strategies widely proposed in these patients. The objective of the current review was to provide an overview on the use of metformin and/or OCs for the management of oligo-amenorrhea in adolescents with PCOS underlining their potential risks and benefits in order to help the clinician to choose the best patients' tailored treatment.
Original language | English |
---|---|
Pages (from-to) | 335-340 |
Number of pages | 6 |
Journal | Gynecological Endocrinology |
Volume | 30 |
Issue number | 5 |
DOIs | |
Publication status | Published - 2014 |
Keywords
- Adolescents
- Metformin
- Oligo-amenorrhea
- Oral contraceptives
- PCOS
ASJC Scopus subject areas
- Endocrinology
- Endocrinology, Diabetes and Metabolism
- Obstetrics and Gynaecology
- Medicine(all)